Indatraline: Difference between revisions
CubanSkiier (talk | contribs) m There was a word that needed to be capitalized at the beginning of a sentence. |
m Grammar Tags: Visual edit Mobile edit Mobile web edit Newcomer task Newcomer task: copyedit |
||
| Line 39: | Line 39: | ||
}} |
}} |
||
{{Tone|date=March 2021}} |
{{Tone|date=March 2021}} |
||
'''Indatraline hydrochloride''' ('''Lu 19-005''') is an antidepressive agent and [[Binding selectivity|non-selective]] [[monoamine transporter]] inhibitor that blocks the [[reuptake]] of [[dopamine]], [[norepinephrine]], and [[serotonin]], with similar efficacy to [[cocaine]].<ref>{{cite journal | vauthors = Cho YS, Yen CN, Shim JS, Kang DH, Kang SW, Liu JO, Kwon HJ | title = Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR/S6 kinase signaling pathway | journal = Scientific Reports | volume = 6 | issue = 1 | pages = 34655 | date = October 2016 | pmid = 27694974 | pmc = 5046148 | doi = 10.1038/srep34655 }}</ref> However, the effects of indatraline have a slower onset and longer duration than cocaine |
'''Indatraline hydrochloride''' ('''Lu 19-005''') is an antidepressive agent and [[Binding selectivity|non-selective]] [[monoamine transporter]] inhibitor that blocks the [[reuptake]] of [[dopamine]], [[norepinephrine]], and [[serotonin]], with similar efficacy to [[cocaine]].<ref>{{cite journal | vauthors = Cho YS, Yen CN, Shim JS, Kang DH, Kang SW, Liu JO, Kwon HJ | title = Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR/S6 kinase signaling pathway | journal = Scientific Reports | volume = 6 | issue = 1 | pages = 34655 | date = October 2016 | pmid = 27694974 | pmc = 5046148 | doi = 10.1038/srep34655 }}</ref> However, the effects of indatraline have a slower onset and longer duration than cocaine. Suggesting that, the compound may be used to treat cocaine addictions.<ref>{{cite journal | vauthors = Negus SS, Brandt MR, Mello NK | title = Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 291 | issue = 1 | pages = 60–69 | date = October 1999 | pmid = 10490887 }}</ref> Lu 19-005 has been shown to block the action of [[methamphetamine]] and [[MDMA]] in laboratory experiments.<ref>{{cite journal | vauthors = Rothman RB, Partilla JS, Baumann MH, Dersch CM, Carroll FI, Rice KC | title = Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse | journal = Synapse | volume = 35 | issue = 3 | pages = 222–227 | date = March 2000 | pmid = 10657029 | doi = 10.1002/(SICI)1098-2396(20000301)35:3<222::AID-SYN7>3.0.CO;2-K | s2cid = 16190813 | url = https://zenodo.org/record/1235504 }}</ref> |
||
==Methylation== |
==Methylation== |
||
Revision as of 10:34, 31 January 2023
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H15Cl2N |
| Molar mass | 292.20 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
 | This article's tone or style may not reflect the encyclopedic tone used on Wikipedia. (March 2021) |
Indatraline hydrochloride (Lu 19-005) is an antidepressive agent and non-selective monoamine transporter inhibitor that blocks the reuptake of dopamine, norepinephrine, and serotonin, with similar efficacy to cocaine.[1] However, the effects of indatraline have a slower onset and longer duration than cocaine. Suggesting that, the compound may be used to treat cocaine addictions.[2] Lu 19-005 has been shown to block the action of methamphetamine and MDMA in laboratory experiments.[3]
Methylation
If indatraline is N-alkylated at the amino group, it is possible to slow the onset of action so that it is not until N-demethylation occurs that the molecules become active. N-methylindatraline has a much longer duration than indatraline because norindatraline is inactive, whereas demethylating N-methylindatraline does not terminate the actions of the parent compound. Effects of N-dimethylindatraline start about 20–30 minutes after administration, making it less likely to be abused than cocaine.[4]
Synthesis
Two main routes have been reported. The first route shown is the original one reported by Bøgesø and co-workers.[5]
The other had been adapted to scale-up:[6]
Another method involves the contraction of a dihydronaphthalene (6–6 fused system) to form the 6–5 indane skeleton.[7]
Routes based on 1-indanone types of intermediates are not as simple as a direct reduction of an imine or oxime. It is reported that the undesirable cis diastereomers are formed instead of the desirable trans isomers. This adds an extra step to the synthetic route. First, the ketones are reduced to get mostly cis alcohols. Second, the cis alcohols are converted to the corresponding mesylates conserving stereochemistry. Third, the mesylates can then be reacted with e.g. N-methylbenzylamine, affecting a Walden inversion (SN2). Finally, the removal of the benzyl affords the product as a racemic mixture.
See also
References
- ^ Cho YS, Yen CN, Shim JS, Kang DH, Kang SW, Liu JO, Kwon HJ (October 2016). "Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR/S6 kinase signaling pathway". Scientific Reports. 6 (1): 34655. doi:10.1038/srep34655. PMC 5046148. PMID 27694974.
- ^ Negus SS, Brandt MR, Mello NK (October 1999). "Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys". The Journal of Pharmacology and Experimental Therapeutics. 291 (1): 60–69. PMID 10490887.
- ^ Rothman RB, Partilla JS, Baumann MH, Dersch CM, Carroll FI, Rice KC (March 2000). "Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse". Synapse. 35 (3): 222–227. doi:10.1002/(SICI)1098-2396(20000301)35:3<222::AID-SYN7>3.0.CO;2-K. PMID 10657029. S2CID 16190813.
- ^ Gardner EL, Liu X, Paredes W, Giordano A, Spector J, Lepore M, et al. (October 2006). "A slow-onset, long-duration indanamine monoamine reuptake inhibitor as a potential maintenance pharmacotherapy for psychostimulant abuse: effects in laboratory rat models relating to addiction". Neuropharmacology. 51 (5): 993–1003. doi:10.1016/j.neuropharm.2006.06.009. PMID 16901516. S2CID 20465584.
- ^ Bøgesø KP, Christensen AV, Hyttel J, Liljefors T (December 1985). "3-Phenyl-1-indanamines. Potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptake". Journal of Medicinal Chemistry. 28 (12): 1817–28. doi:10.1021/jm00150a012. PMID 2999402.
- ^ Froimowitz M, Wu KM, Moussa A, Haidar RM, Jurayj J, George C, Gardner EL (December 2000). "Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse". Journal of Medicinal Chemistry. 43 (26): 4981–92. doi:10.1021/jm000201d. PMID 11150168.
- ^ Silva LF, Siqueira FA, Pedrozo EC, Vieira FY, Doriguetto AC (April 2007). "Iodine(III)-promoted ring contraction of 1,2-dihydronaphthalenes: a diastereoselective total synthesis of (±)-indatraline". Organic Letters. 9 (8): 1433–6. doi:10.1021/ol070027o. PMID 17371034.